Antoni Wiedlocha funded by the EEA Poland-Norway grants
Antoni Wiedlocha
The proposal "Novel targeted therapy based on dual warhead conjugates against FGFR dependent cancers", with senior scientist Antoni Wiedlocha at Department of Molecular Cell Biology, Institute for Cancer Research, as Norwegian partner and professor Jacek Otlewski at the University of Wroclaw as Polish parther, has been awarded funding from the EEA Poland-Norway grants under the "Applied Research" programme.
Links:
From the National Centre for Research and Development in Poland:
Published in Level 2 journals, first or last author from Oslo University Hospital.
Assis DN, Hov JR(2025) Phase 2 Clinical Trials in Primary Sclerosing Cholangitis: Making the Most of Every Opportunity? J Hepatol(in press) DOI 10.1016/j.jhep.2025.10.022, PubMed 41197906
Vidnes TK, Wahl AK, Larsen MH, Meyer KB, Engebretsen E, Hermansen Å, Urstad KH, Dahl KG, Borge CR, Andersen MH(2025) Corrigendum to "Effectiveness of a health communication intervention on health literacy in the first year following kidney transplantation - A randomized controlled study" [Patient Educ Couns 123 (2024) 108207] Patient Educ Couns, 142, 109403(in press) DOI 10.1016/j.pec.2025.109403, PubMed 41197493
Tveten IE, Nyberg J, Grue JF, Helland RH, Melichova D, Nguyen TM, Brunvand H, Edvardsen T, Haugaa KH, Dalen H, Løvstakken L, Grenne B, Østvik A(2025) Deep Learning Segmentation and Quantification of the Left Ventricle from the Parasternal Short-Axis View in Echocardiography Ultrasound Med Biol(in press) DOI 10.1016/j.ultrasmedbio.2025.10.005, PubMed 41188093